25 September 2018
Cytox expands collaboration with AIBL to identify those most at risk to rapidly progress to Alzheimer’s
Oxford & Manchester, UK. Cytox, a precision medicine company which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s and other neurological diseases, has announced it has expanded its research...
18 September 2018
NPIF - Maven Equity Finance and Catapult Ventures, alongside new Manchester Tech Trust angel group, invest £700,000 in Biorelate
Manchester-based technology platform creates innovative solution for data curation in biomedicine … NPIF - Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the Northern Powerhouse Investment Fund, has invested £200,000 as part of a...
13 September 2018
GM&C Life Sciences Fund announces 25th investment
Investment in digital healthcare company Rinicare is milestone deal for Fund … Alderley Park, UK, 13th September 2018 – The GM&C Life Sciences Fund, managed by Catapult Ventures, has announced its 25th investment by completing the funding of Alderley Park based...
11 September 2018
Yospace, Spotx and Kaltura come together on advanced advertising
New York, NY, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Kaltura, the leading video technology provider, today announced the release of its Advanced Advertising solution, which leverages the company’s partnership and technology integrations with Yospace, a leading dynamic ad...
22 August 2018
Catapult exits Stagecoach
Enderby, UK - 22nd August 2018. Catapult portfolio company Stagecoach Theatre Arts Limited (“Stagecoach”) has been sold to Trafalgar Entertainment Group Limited (“Trafalgar”), a live theatre and entertainment business, generating a profitable exit for the...
22 August 2018
CLYZ Labs announces seed funding from Catapult Ventures to develop Cancertain™ test for personalised cancer treatment
Manchester UK, 15th August 2018 – CLYZ Labs, an award-winning early-stage cancer diagnostics company, today announced that the first clinical trial involving its innovative Cancertain™ test has secured all regulatory approvals following a seed investment from the...
15 August 2018
Blueberry Therapeutics Limited closes £10m funding to support development of nanomedicines portfolio
Alderley Park, UK, 14 August 2018– Blueberry Therapeutics Limited, (“Blueberry Therapeutics”) a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, today announces that it has...
7 August 2018
Nexus Labs announces seed funding from Catapult Ventures and BioCity to launch SurgicalTeaching.com
Alderley Park, UK 1 st August 2018. Nexus Labs, a pioneering medical education startup, today announced the completion of a Seed funding round to launch its first product, SurgicalTeaching.com a digital platform aimed at enhancing the learning experience of students and doctors...
31 July 2018
Abzena signs protein engineering agreement with NYU Langone Health
Cambridge, UK, 30 July 2018 – Abzena plc (AIM: ABZA, ‘Abzena’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has entered into a master service agreement with one of...
17 July 2018
Innovate UK Announces Precision Medicines Innovation Fund
Improving diagnosis and treatment of disease: new innovation fund … UK businesses can apply for simultaneous grant funding and venture capital investment in precision medicine projects. There is simultaneous grant and venture capital funding available for small and medium...